Additional mRNA COVID-19 Vaccine Dose

Additional mRNA COVID-19 Vaccine Dose

After initial 2-dose primary mRNA COVID-19 vaccine series for immunocompromised people

 
For individuals moderately to severely immunocompromised, the FDA has authorized an additional dose of COVID-19 vaccine following the two-shot primary vaccine series for mRNA vaccine manufactured by Pfizer or Moderna.*

This third shot is to be given at least 28 days after the second dose and is recommended for people who are moderately and severely immunocompromised only due to a health condition or medical treatment such as:
Active treatment for solid tumor and hematologic malignancies
Receipt of solid-organ transplant and taking immunosuppressive therapy
Receipt of CAR-T-Cell or hematopoietic stem cell transplant
Moderate or severe primary immunodeficiency
Advanced or untreated HIV infection
Active treatments with high-dose corticosteroids, alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, TNF blockers and other biologic agents that are immunosuppressive or immunomodulatory.

If you know you have one of the health conditions or are receiving one of the treatments above, you may schedule your appointment at NMRMC Family Medicine Clinic at 620-432-5592 or other participating clinics/pharmacies.   

If you don’t know if you qualify for a third dose of mRNA COVID vaccine (Pfizer or Moderna), call your provider.
 
The CDC and ACIP (Advisory Committee on Immunization Practices) emphasize the clinical considerations for use of an additional dose of an mRNA COVID-19 vaccine apply only to people who are moderately or severely immunocompromised.
 
*Janssen (Johnson & Johnson) COVID-19 vaccine is not authorized for an additional dose at this time.  Currently, there is not enough data to determine if an additional dose of J&J vaccine will improve immune response in people who are immunocompromised.
 
Additional Dose Attestation  You can see a copy of the form patients must sign prior to receiving the additional COVID-19 booster.  Additional Dose Attestation (kansasvaccine.gov)
 
Learn more on the CDC Website Here.